Pancreatic Cancer Research

ReviewCell Oncol (Dordr)2020

DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.

Journal
Cell Oncol (Dordr)
Published
5 June 2020
Citations
91
Type
Review

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background Pancreatic cancer or pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating cancer types with a 5-year survival rate of only 9%. PDAC is one of the leading causes of cancer-related deaths in both genders. … Excerpt only: this text is the publisher’s. Read it in full at the source.